Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Lurasidone effective in acute exacerbation of schizophrenia

Oct. 26, 2005

Blocking P-glycoprotein increases Abeta accumulation

Oct. 26, 2005

Abbott profiles its new highly selective dopamine D4 receptor agonist

Oct. 26, 2005

New mGluR1 antagonist shows promise as an analgesic

Oct. 26, 2005

Phase II study of Gabapentin GR completes enrollment

Oct. 26, 2005

Oxycyte produces positive results in preclinical traumatic brain injury study

Oct. 26, 2005

Lilly to support study of Corlux to mitigate olanzapine-associated weight gain

Oct. 26, 2005

Repligen in expanded uridine agreement for bipolar disorder

Oct. 26, 2005

Memory Pharmaceuticals and Amgen sign agreement on PDE10 inhibitors

Oct. 26, 2005

Recent patents describe novel therapeutic agents for depression, anxiety, etc.

Oct. 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026